Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5569441

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CCc1cccc2cc(O)cc(-c3ncc4c(N5C[C@H]6CC[C@@H](C5)N6)nc(OC[C@@H]5CCCN5C)nc4c3F)c12

Basic Information

ChEMBL ID CHEMBL5569441
Phase Preclinical
Structure Type MOL
InChI Key IKRAZJPDLDPIBG-BDTNDASRSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

542.7
MW (Da)
4.67
ALogP
8
HBA
2
HBD
86.6
PSA (Ų)
0.36
QED
1
Ro5 Violations
6
Rot. Bonds

Drug Information

Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C31H35FN6O2
MW 542.66
Aromatic Rings 4
Heavy Atoms 40
NP-Likeness -0.17

Activity Summary

IC50 1 meas. best 8.24

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
GTPase KRas
CHEMBL2189121
IC50 8.24 8.24 5.8 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
GTPase KRas IC50 = 5.8 nM 8.24 Inhibition of KRAS G12D mutant (unknown origin) preincubated for 15 mins followe... 38197882

Literature References

PubMed DOI Target Context # Activities
38197882 10.1021/acs.jmedchem.3c01622 GTPase KRas 1

Data from ChEMBL 36 via Core Engine